Related Experiment Video
Updated: May 22, 2026
05:08
Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Rediscovering pluripotency: from teratocarcinomas to embryonic stem cells. Cardiff, 10-12 October 2011
Ivana Barbaric1, Neil J Harrison
1Centre for Stem Cell Biology and the Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield, UK. i.barbaric@sheffield.ac.uk
Summary
Embryonal carcinoma cells, derived from teratocarcinoma, are foundational to understanding pluripotent stem cells and regenerative medicine. Research continues to explore their genetic makeup and developmental control mechanisms.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Cancer Research
Background:
- Embryonic stem cells (ESCs) hold significant promise for regenerative medicine.
- The study of embryonal carcinoma cells (ECCs), derived from teratocarcinoma, is crucial for understanding pluripotency.
- A 2011 meeting provided historical context on ECC research and its impact on current stem cell science.
Framework:
- The meeting focused on the genetic and epigenetic characteristics of pluripotent stem cells.
- Mechanisms controlling stem cell fate determination were a key area of discussion.
- The relationship between pluripotent stem cells and the early embryo was explored.
Implementation:
- Early pioneers in the field presented their ongoing research.
- Speakers revisited foundational questions in stem cell biology.
- The event facilitated a review of progress and future challenges in the field.
Implications:
- Understanding ECCs is vital for advancing regenerative medicine therapies.
- Continued research into stem cell genetics and epigenetics is necessary.
- Further investigation into stem cell fate mechanisms will guide therapeutic development.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:14Maintenance of the ES Cell State
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...